Innovative medicines can bring hope to people with rare diseases – let’s get them to patients, says Paul Catchpole director of Value and Access policy, Association of the British Pharmaceutical Industry.
Today’s publication of England’s Action Plan for Rare Diseases contains important commitments to ensure that people with rare diseases get faster diagnosis, better care and timelier access to the treatments they desperately need.
At the ABPI, we will be working to ensure the England plan can deliver for patients, and that plans are also created and delivered for Scotland, Wales and Northern Ireland. Patients from all across the UK must benefit.